Success Metrics

Clinical Success Rate
88.9%

Based on 16 completed trials

Completion Rate
89%(16/18)
Active Trials
0(0%)
Results Posted
13%(2 trials)
Terminated
2(10%)

Phase Distribution

Ph phase_3
3
14%
Ph not_applicable
7
33%
Ph phase_2
3
14%
Ph phase_4
6
29%

Phase Distribution

0

Early Stage

3

Mid Stage

9

Late Stage

Phase Distribution19 total trials
Phase 2Efficacy & side effects
3(15.8%)
Phase 3Large-scale testing
3(15.8%)
Phase 4Post-market surveillance
6(31.6%)
N/ANon-phased studies
7(36.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

16 of 18 finished

Non-Completion Rate

11.1%

2 ended early

Currently Active

0

trials recruiting

Total Trials

21

all time

Status Distribution
Active(1)
Completed(16)
Terminated(2)
Other(2)

Detailed Status

Completed16
Terminated2
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (15.8%)
Phase 33 (15.8%)
Phase 46 (31.6%)
N/A7 (36.8%)

Trials by Status

terminated210%
completed1676%
not_yet_recruiting15%
unknown210%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07566065Not Applicable

Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis

Not Yet Recruiting
NCT01121224Phase 4

Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty

Completed
NCT03311360

Drug Coated Balloon Versus Stenting in Patients With Symptomatic Vertebral Artery Stenosis:an Observational Clinical Study

Completed
NCT02456402Not Applicable

Drug Coated Balloon Compared to Bare Metal Stent for de Novo Coronary Artery Lesions

Completed
NCT03671655Not Applicable

Excellence in Peripheral Arterial Disease Treatment of Superficial Femoral Artery Disease With Drug-eluting Stents

Terminated
NCT02504307Phase 4

OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation

Completed
NCT01543373Not Applicable

Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS

Completed
NCT00433966Phase 3

Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction

Completed
NCT00856765Phase 2

Drug-eluting Balloon in Acute Myocardial Infarction

Completed
NCT00462631Phase 2

Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients

Completed
NCT01093391Phase 3

A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus

Completed
NCT02504034Not Applicable

Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein

Unknown
NCT00595647Phase 4

Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions

Terminated
NCT01839890Phase 3

Paclitaxel Eluting Balloon in St Elevation Myocardial Infarction

Completed
NCT01867034Not Applicable

Soluble Receptors for Advanced Glycation End-Products and PCI

Unknown
NCT00825279Phase 4

A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent

Completed
NCT01036048

A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

Completed
NCT00283413Not Applicable

Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts

Completed
NCT00755443Phase 4

Sirolimus-Eluting Stent Versus Standard Stent in Diabetic

Completed
NCT00627900Phase 4

Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
21